drugset / Trial / NCT03289325

Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery

NCT03289325 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

A retrospective study showed that intraoperative dexmedetomidine administration was associated with decreased risk of 1-year mortality after cardiac surgery. In a previous randomized controlled trial, 285 elderly patients undergoing cardiac surgery were randomized to receive either perioperative dexmedetomidine or placebo (normal saline) administration. The purpose of this 6-year follow-up study is to investigate whether perioperative dexmedetomidine can improve long-term outcomes in those recruited elderly patients after cardiac surgery.

Timeline

Start
2021-10-21
Primary completion
2022-05-03
Completion
2022-05-03

Outcome

Missed primary endpoint

paper there were 18 deaths (12.6%) with placebo versus 22 deaths (15.5%) with dexmedetomidine; hazard ratio (HR) 1.22, 95% CI 0.65 to 2.27, p = 0.418. PMID 40097932 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg Intravenous